Zobrazeno 1 - 5
of 5
pro vyhledávání: '"C R, Becerra"'
Autor:
D. Pollyea, L. Gore, J. Gutman, S. G. Eckhardt, N. Hagelstrom, S. Coutre, M. Thirman, J. Byrd, G. Massimini, B. Laffranchi, N. Rejeb, E. Asatiani, A. Milner, O. von Richter, G. Locatelli, J. A. Ogden, B. Osterwalder, R. Meng, L. R. Molife, L. de Mattos-Arruda, A. Hollebecque, S. J. Isakoff, D. Roda, Y. Yan, A. Cervantes, J. C. Soria, J. Mateo, G. Argiles, J. C. Bendell, A. El-Khoueiry, D. J. Jonker, M. B. Sawyer, L. Wong, C. R. Becerra, J. M. Chemidlin, G. Kollia, D. S. A. Nuyten, C. J. Twelves, D. K. Wilkins, A. Anthoney, J. Chappell, W. T. Ng, P. T. Turner, R. Kristeleit, O. Schoenborn-Kellenberger, A. Suder
Publikováno v:
Annals of Oncology. 24:i33-i35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::896d1e663b4e01b7ec3824f42a176deb
https://doi.org/10.1093/annonc/mdt048
https://doi.org/10.1093/annonc/mdt048
Autor:
D I, Rosenthal, P, Nurenberg, C R, Becerra, E P, Frenkel, D P, Carbone, B L, Lum, R, Miller, J, Engel, S, Young, D, Miles, M F, Renschler
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(4)
Gadolinium Texaphyrin (Gd-Tex) is a radiation sensitizer with a novel mechanism of action that sensitizes both oxic and hypoxic cells, localizes selectively in tumors, and is detectable by magnetic resonance imaging (MRI). This Phase I single-dose tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1ce077eae48fe6242c021f18af392256
https://pubmed.ncbi.nlm.nih.gov/10213207
https://pubmed.ncbi.nlm.nih.gov/10213207
Autor:
M. M. Sgroi, N. H. Hanna, A. D. McCollum, N. Bechar, M. DiMaio, Z. Hammoud, M. Yu, H. Choy, C. R. Becerra
Publikováno v:
Journal of Clinical Oncology. 26:4564-4564
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee0410a1548a8deb2430a0c25c043975
https://doi.org/10.1200/jco.2008.26.15_suppl.4564
https://doi.org/10.1200/jco.2008.26.15_suppl.4564
Publikováno v:
Journal of Clinical Oncology. 22:4125-4125
4125 Background: T607 (a compound related to T67) is a novel irreversible tubulin inhibitor currently undergoing Phase 2 investigation for the treatment of various malignancies. Methods: In this Ph...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::edcd9c06024996ebd03c9a8cd93b329d
https://doi.org/10.1200/jco.2004.22.90140.4125
https://doi.org/10.1200/jco.2004.22.90140.4125
Publikováno v:
Journal of Neuropathology and Experimental Neurology. 56:594
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30099d9e5ecee73376e036f2bc4a90fb
https://doi.org/10.1097/00005072-199705000-00107
https://doi.org/10.1097/00005072-199705000-00107